UNSPSC 51284304: Racefenicol or racephenicol

This classification denotes an antibiotic with the molecular formula C12H15Cl2NO5S, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 283383NO13, chemically known as (+-)-threo-2,2-dichloro-n-(beta-hydroxy-alpha-(hydroxymethyl)-p-(methylsulfonyl)phenethyl)acetamide but more generally known as racefenicol, which bears U.S. National Institutes of Health Compound Identifier 5433. The European Medicines Agency schedules Racefenicol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10231MIG.

UNSPSC 51284304 Racefenicol or racephenicol, a Commodity code, shows minimal alignment between its nominal scope and actual state and local procurement activity. The recent opportunities tagged to this code instead reflect purchasing for emergency medical supplies, naloxone and drug deactivation systems, direct-to-manufacturer pharmacy programs, and generic pharmaceuticals—none of which concern racefenicol, an antibiotic pharmaceutical compound. State and local issuers posting under this code appear to be health departments, fire rescue divisions, and cooperative purchasing alliances sourcing a broad range of medical and pharmacy products rather than a specific pharmaceutical ingredient.

Geographically, recent activity spans Florida (Seminole County), Texas (Health and Human Services Commission), and a multistate cooperative (Minnesota Multistate Cooperative Purchasing Alliance serving Minnesota and Oregon participants). Representative opportunities include Seminole County's IFB for naloxone and drug deactivation systems (IFB60459723LAS, due July 26, 2026), the City of Tampa Fire Department's sealed bid for medical and first aid supplies with a $700,000 estimated contract value and SLBE set-aside (26P00145, due March 13, 2026), the Texas HHS Commission's Request for Information on direct-to-manufacturer prescriptions (HHS0017013, posted April 3, 2026), and the Minnesota Multistate Cooperative Purchasing Alliance's RFP for generic multi-source pharmaceuticals and OTC products (S1070000015802, due March 26, 2026). The code's tagging suggests a potential data-classification error; bidders seeking opportunities in emergency medical supplies or state pharmacy programs should verify the actual commodity scope through each solicitation rather than relying on this UNSPSC designation.